Showing results (611-620 of 628) with videos related to

Sort By:
Pageof 63
JTO Clinical and Research Reports|November 14, 2025
Characteristics of Short-Term Survivors With ALK or ROS1-Altered Metastatic NSCLCKai-Lin Liu, Alex Watts, Connor B Grady, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsMikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, et al.
Cancer Discovery|September 22, 2025
The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancerMarco Avolio, Simonetta M Leto, Francesco Sassi, et al.
Nature Communications|March 2, 2022
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosisDiego Sáenz de Urturi, Xabier Buqué, Begoña Porteiro, et al.
Environmental Research|April 18, 2026
Multi-media occurrence, bioaccumulation, and exposure assessment of PFAS across a Midwestern U.S. StateMaria S Sepúlveda, Lisa Brown, Staci L Capozzi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2026
Germline determinants of risk and molecular subtype in young-onset lung cancerJaclyn LoPiccolo, Ryan L Collins, Noah Fields, et al.
JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2025
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled TrialByoung Chul Cho, Weimin Li, Alexander I Spira, et al.
The Lancet. Oncology|December 16, 2019
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trialsRobert C Doebele, Alexander Drilon, Luis Paz-Ares, et al.
Hepatology (Baltimore, Md.)|July 28, 2025
E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5pMaider Apodaka-Biguri, André L Simão, Francisco González-Romero, et al.
Pageof 63